Aspen Aerogels, Inc. · NYSE:ASPN
Aspen Aerogels — Q4 2022 Earnings Presentation
12 slides from Aspen Aerogels's earnings presentation, Feb 16, 2023
Slide 1: Aspen Aerogels Q4 2022 Financial Results Call
February 16, 2023 ASPEN AEROGELS Q 4 2 0 2 2 F I N A N C I A L R E S U LT S C A L L
Slide 2: Disclaimer on Forward Looking Statements
Disclaimer on Forward Looking Statements This presentation contains statements that constitute “forward‐looking statements” under the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “believe,” “could,” “estimate,” “expect,” “guidance,” “intend,” “may,” “plan,” “potential,”
Slide 3: Disclaimer on Forward Looking Statements
Disclaimer on Forward Looking Statements The presentation contains information regarding certain financial targets with respect to the Company. Such financial targets constitutes forward looking information and is for illustrative purposes only and should not be relied upon as necessarily being indi
Slide 4: Q4 2022 Developments and Year-End Highlights
Q4 2022 Developments and Year-End Highlights Strong demand across our segments drove 62% quarterly revenue growth that enabled 48% annual revenue growth. Recent Highlights November 2022 – Fundraising Recap $ in millions • Grew total annual revenue by 48% year-over year Equity 100 Loan • Delivered 24
Slide 5: Q4 2022 and Full Year Financial Highlights
Q4 2022 and Full Year Financial Highlights $59.6M quarterly revenue run rate drove gross margin expansion during continued period of investment in growth. $ in millions except per share figures Q4 2021 Q4 20221 2021 20221 Commentary Quarterly Trajectory Quarterly revenue growth Revenues - $M support
Slide 6: 2023 Financial Outlook
2023 Financial Outlook Wide range in revenue guidance is driven by expected steep increase in EV Thermal Barrier demand in Q3 and Q4. Commentary $ in millions except per share figures 2023 Outlook 2023 GM Ultium EV Production Forecast 3 Vehicles in thousands Wide range driven by potential 78% steep
Slide 7: Plant II – Phase 1 Construction Update
Plant II – Phase 1 Construction Update $135M cost increase, but on target for driving an increase in capacity to fulfill a higher range of demand beyond 2024. Phase 1 Cost Estimate Summary Total Estimated Revenue Capacity $ in millions $ in millions Plant I Estimates 710 Original East 250 Spent to D
Slide 8: EV Thermal Barrier Award and Quote Pipeline
EV Thermal Barrier Award and Quote Pipeline NMC and LFP, Prismatic or Pouch cell EV batteries present a $15B revenue opportunity within grasp through 2030. Estimated Award and Region Customer Sourcing Approach NMC or LFP Form Factors Commercial Status Quote Value 1 Battery Platform Pouch Awarded - I
Slide 9: Summary
Summary Earning our right to win by leveraging the Aerogel Technology Platform TM, executing, and investing to grow profitably. DEMONSTRATED OPERATING EXECUTION Strong Q4 revenue and gross profit showed what our manufacturing capacity can deliver on short notice. ADVANCED PYROTHIN® COMMERCIAL PROGRE
Slide 10: Appendix
Appendix GAAP-Non-GAAP Reconciliation
Slide 11: GAAP to Non-GAAP Reconciliation
GAAP to Non-GAAP Reconciliation Q4 Fiscal Year FY 2023 Outlook ($ in thousands) 2022 2021 2022 2021 Low High Net loss (9,609) (16,353) (82,738) (37,094) (101,900) (91,900) Depreciation and Amortization 2,530 2,584 9,222 9,440 22,300 22,300 Stock-based Compensation 2,672 1,576 9,385 5,176 11,000 11,0
Slide 12: - ASPEN|acrogels
- ASPEN|acrogels